Post-treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder
✍ Scribed by H. Blair Simpson; Michael R. Liebowitz; Edna B. Foa; Michael J. Kozak; Andrew B. Schmidt; Vivienne Rowan; Eva Petkova; Kevin Kjernisted; Jonathan D. Huppert; Martin E. Franklin; Sharon O. Davies; Raphael Campeas
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 113 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.20003
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## The current study examines the neuroendocrine response to intravenous clomipramine (IV CMI) in oral CMI-resistant obsessive-compulsive disorder (OCD) patients on day 1 and day 14 of treatment to identify predictors of response. Forty-four OCD patients with an inadequate response or poorly toleran
The introduction of the SSRIs (selective serotonin reuptake inhibitors) over the past decade has provided exciting new opportunities for the treatment of obsessive-compulsive disorder (OCD). The serotonin hypothesis, based on the preferential response of OCD to the serotonin reuptake inhibitor, clom
Obsessive compulsive disorder (OCD) often has burdensome and debilitating effects on families. Family responses range from support and empathy to excessive accommodation and overinvolvement to hostility and rejection. Assessment of individual family members' responses in these arenas help determine